2024 Laboratory Reimbursement Trends and What to Expect in 2025
Revenue cycle management experts weigh in on the biggest developments of 2024 and how labs can best prepare for 2025 and beyond
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Revenue cycle management experts weigh in on the biggest developments of 2024 and how labs can best prepare for 2025 and beyond
When structuring business arrangements, addressing six key risk areas can help laboratories avoid major compliance issues.
Ann Lambrix, vice president of RCM Solutions at Lighthouse Lab Services, discusses key developments in lab billing and coding.
Recent cases show labs should be wary of issues such as improper relationships, medical necessity, kickbacks, and potential telehealth fraud.
Understanding the 2024 CLFS update—and the changes that are still to come.
What clinical validation really means—and why every member of the laboratory should understand it.
Audits can be helpful not just for compliance purposes, but for maximizing reimbursement and maintaining a healthy business.
ASCP chief medical officer Ali Brown, MD, FASCP, discusses the highlights of 2023 and ASCP’s plans for supporting its members in 2024.
Though things appeared status quo in 2023, last year may prove to be a turning point for the laboratory industry.
An overview of the key 2023 mergers and acquisitions in the diagnostics industry and the trends they reveal.
G2’s list of major FDA approvals includes cancer and liquid biopsy, COVID-19, STI, and neurologic tests.